Jeff Yass’s Viemed Healthcare VMD Stock Holding History

Jeff Yass’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$860K	Buy	75,429 +46,940	+165%	+$465K	﹤0.01%	8581
2026 Q1	$262K	Buy	28,489 +11,460	+67%	+$95.4K	﹤0.01%	11162
2025 Q4	$127K	Buy	+17,029	New	+$117K	﹤0.01%	11310
2025 Q3	–	Sell	-44,747	Closed	-$309K	–	14007
2025 Q2	$309K	Sell	44,747 -5,638	-11%	-$38.3K	﹤0.01%	10274
2025 Q1	$367K	Buy	50,385 +23,547	+88%	+$185K	﹤0.01%	9613
2024 Q4	$215K	Buy	26,838 +16,158	+151%	+$140K	﹤0.01%	10569
2024 Q3	$78.3K	Buy	+10,680	New	+$76.3K	﹤0.01%	11183
2024 Q1	–	Sell	-17,675	Closed	-$139K	–	13435
2023 Q4	$139K	Buy	+17,675	New	+$128K	﹤0.01%	11043
2023 Q3	–	Sell	-26,764	Closed	-$262K	–	13073
2023 Q2	$262K	Sell	26,764 -185,129	-87%	-$1.88M	﹤0.01%	9714
2023 Q1	$2.05M	Buy	211,893 +184,501	+674%	+$1.61M	﹤0.01%	5084
2022 Q4	$207K	Buy	+27,392	New	+$185K	﹤0.01%	10038
2022 Q3	–	Sell	-46,012	Closed	-$295K	–	14196
2022 Q2	$248K	Buy	46,012 +34,846	+312%	+$188K	﹤0.01%	10088
2022 Q1	$56K	Buy	+11,166	New	+$51.8K	﹤0.01%	12267

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Jeff Yass's VMD Position: Q2 2026 in Review

Jeff Yass increased its Viemed Healthcare (VMD) stake by 165% in Q2 2026, buying an estimated $465K and bringing the position to 75,429 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #8581.

Jeff Yass first reported a position in VMD in Q1 2022 and has held it in 13 quarters since. The position peaked at $2.05M in Q1 2023. 165 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Jeff Yass held 75,429 shares of Viemed Healthcare worth $860K as of Q2 2026.
Jeff Yass bought 46,940 Viemed Healthcare shares in Q2 2026, an estimated $465K.
Viemed Healthcare made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8581 holding.
Jeff Yass first reported a position in Viemed Healthcare in Q1 2022 and has held it in 13 quarters since.
Jeff Yass's Viemed Healthcare position peaked at $2.05M in Q1 2023.
165 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.